Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bio-Rad Laboratories (BIO)

535.07   11.84 (2.26%) 11-29 21:17
Open: 525.78 Pre. Close: 523.23
High: 536.35 Low: 521.4
Volume: 274,360 Market Cap: 15,912M
Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 537.262 - 539.829 539.829 - 542.159
Low: 515.055 - 518.053 518.053 - 520.774
Close: 530.094 - 535.058 535.058 - 539.565

Technical analysis

as of: 2020-11-29 9:19:07 AM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 694.33     One year: 757.32
Support: Support1: 507.22    Support2: 422.01
Resistance: Resistance1: 594.46    Resistance2: 648.39
Pivot: 574.15
Moving Average: MA(5): 539.96     MA(20): 582.33
MA(100): 534.45     MA(250): 454.66
MACD: MACD(12,26): -7.93     Signal(9): 2.04
Stochastic oscillator: %K(14,3): 12.56     %D(3): 10.16
RSI: RSI(14): 40.78
52-week: High: 648.39  Low: 309.38  Change(%): 44.0
Average Vol(K): 3-Month: 17522  10-Days: 25830

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
BIO has closed above bottom band by 19.7%. Bollinger Bands are 108.8% wider than normal. The large width of the bands suggest high volatility as compared to BIO's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue.

Headline News

Sun, 29 Nov 2020
Quantitative PCR Market Swot Analysis By Key Players Bio-Rad Laboratories, QIAGEN, Roche, Thermo Fisher Scientific, Becton, Dickinson and Company, Abbott, Siemens Healthcare, bioMérieux SA, Danaher, Agilent Technologies - Cheshire Media

Sat, 28 Nov 2020
Bio-Rad Laboratories, Inc. (NYSE:BIO): Up 43.44% in 2020, Outlook Remains Strong - Stocks Register

Fri, 27 Nov 2020
Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio - Yahoo Finance

Wed, 25 Nov 2020
Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock: Buy, Hold, or Sell? - InvestorsObserver

Wed, 25 Nov 2020
Bio-Rad Laboratories Inc. [BIO] Analysis: Why BIO Stock Is dripping down Today - MZP News

Thu, 19 Nov 2020
Global Protein Crystallization and Crystallography Market | Key Vendors Include Bio-Rad Laboratories Inc., Bruker Corp., Corning Inc., and Others | Technavio - Business Wire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 25
Shares Float (M) 21
% Held by Insiders 14.36
% Held by Institutions 78.04
Shares Short (K) 414
Shares Short P. Month (K) 360

Stock Financials

EPS 116.690
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 295.840
Profit Margin 147.91
Operating Margin 13.58
Return on Assets (ttm) 2.1
Return on Equity (ttm) 50.5
Qtrly Rev. Growth 15.5
Gross Profit (p.s.) 50.930
Sales Per Share 96.200
EBITDA (p.s.) 18.578
Qtrly Earnings Growth
Operating Cash Flow (M) 450
Levered Free Cash Flow (M) 354

Stock Valuations

PE Ratio 4.59
PEG Ratio 1.09
Price to Book value 1.81
Price to Sales 5.56
Price to Cash Flow 29.39

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.